within Pharmacolibrary.Drugs.ATC.C;

model C01AA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.93,
    Cl             = 0.03333333333333333,
    adminDuration  = 600,
    adminMass      = 0.0002,
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0004633333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Acetyldigitoxin is a cardiac glycoside that was historically used for the treatment of heart failure and certain types of cardiac arrhythmias. It is structurally related to digitoxin and digoxin. Due to its narrow therapeutic index and risk of toxicity, acetyldigitoxin is not commonly used in modern medical practice and has been largely replaced by safer alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult patients based on class properties and old clinical data; no direct recent publication with original PK values identified.</p><h4>References</h4><ol><li><p>Bogdanik, T, et al., &amp; Zambrzycki, J (1974). [Principles of therapeutic algorithm used in the determination of optimal dosage of digitalis derivatives]. <i>Polski tygodnik lekarski (Warsaw, Poland : 1960)</i> 29(43) 1849–1851. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4608627/&quot;>https://pubmed.ncbi.nlm.nih.gov/4608627</a></p></li><li><p>Bodem, G, et al., &amp; Dengler, HJ (1975). [Studies on metabolism and pharmacokinetics of alpha-acetyldigitoxin in man (author&#x27;s transl)]. <i>Arzneimittel-Forschung</i> 25(9) 1448–1452. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1242671/&quot;>https://pubmed.ncbi.nlm.nih.gov/1242671</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01AA01;
